NGVT
Ingevity Corp
$
46.200
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
56.0909
Open
53.090
VWAP
47.32
Vol
561.65K
Mkt Cap
1.68B
Low
45.870
Amount
26.58M
EV/EBITDA(TTM)
8.06
Total Shares
36.33M
EV
3.16B
EV/OCF(TTM)
10.59
P/S(TTM)
1.65
Ingevity Corporation is engaged in developing, marketing, and bringing to market solutions that are renewably sourced. The Company operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. Performance Materials segment engineers, manufactures, and sells hardwood-based, chemically activated carbon products, which are produced through a technical and specialized process primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. Performance Chemicals segment is comprised of two product lines: road technologies and industrial specialties. Its products are utilized in pavement construction, preservation, reconstruction and recycling, agrochemical dispersants, paper chemicals and other diverse industrial uses. Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
285.67M
+0.59%
0.897
-9.43%
279.20M
-6.56%
0.657
-30.79%
360.43M
-4.37%
1.390
+26.36%
Estimates Revision
The market is revising Downward the revenue expectations for Ingevity Corporation (NGVT) for FY2025, with the revenue forecasts being adjusted by -3.3% over the past three months. During the same period, the stock price has changed by -5.50%.
Revenue Estimates for FY2025
Revise Downward
-3.3%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+0.63%
In Past 3 Month
Stock Price
Go Down
-5.50%
In Past 3 Month
2 Analyst Rating
Wall Street analysts forecast NGVT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NGVT is 60.50 USD with a low forecast of 52.00 USD and a high forecast of 69.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 46.200
Low
52.00
Averages
60.50
High
69.00
Current: 46.200
Low
52.00
Averages
60.50
High
69.00
BMO Capital
Outperform
maintain
$62 -> $68
2025-09-05
Reason
BMO Capital
Price Target
$62 -> $68
2025-09-05
maintain
Outperform
Reason
BMO Capital raised the firm's price target on Ingevity to $68 from $62 and keeps an Outperform rating on the shares. The company announced the sale of its CTO Refinery and most of the InSpec business in its Performance Chems platform for a solid high-teens multiple, and the firm sees this reducing earnings volatility and improving the margin profile of the business, the analyst tells investors in a research note.
BMO Capital
John McNulty
Outperform
maintain
$56 -> $62
2025-08-07
Reason
BMO Capital
John McNulty
Price Target
$56 -> $62
2025-08-07
maintain
Outperform
Reason
BMO Capital analyst John McNulty raised the firm's price target on Ingevity to $62 from $56 and keeps an Outperform rating on the shares after its Q2 earnings beat. Despite the solid 21% jump in the stock, the firm sees significant upside ahead for Ingevity as it has reached the inflection point in its earnings and free cash flow, the analyst tells investors in a research note.
Wells Fargo
Michael Sison
Hold
Maintains
$45 → $32
2025-04-09
Reason
Wells Fargo
Michael Sison
Price Target
$45 → $32
2025-04-09
Maintains
Hold
Reason
Wells Fargo lowered the firm's price target on Ingevity to $32 from $45 and keeps an Equal Weight rating on the shares. Given increased risks in a post tariff world, the firm recommends a more defensive position within the chemicals sector into Q1 2025 results as Wells expects cautious outlook commentary.
BMO Capital
John McNulty
Hold
to
Buy
Upgrades
$62 → $65
2025-02-26
Reason
BMO Capital
John McNulty
Price Target
$62 → $65
2025-02-26
Upgrades
Hold
to
Buy
Reason
BMO Capital analyst John McNulty raised the firm's price target on Ingevity to $62 from $61 and keeps a Market Perform rating on the shares after its Q4 earnings beat. The company is starting to reap the benefits of roughly two years of work to escape the pressures of its CTO - Crude Tall Oil - platform, the analyst tells investors in a research note. Ingevity is also seeing its high value add Performance Materials business enjoying growth despite muted end-market volumes, BMO adds.
BMO Capital
John McNulty
Hold
Maintains
$61 → $62
2025-02-20
Reason
BMO Capital
John McNulty
Price Target
$61 → $62
2025-02-20
Maintains
Hold
Reason
BMO Capital analyst John McNulty raised the firm's price target on Ingevity to $62 from $61 and keeps a Market Perform rating on the shares after its Q4 earnings beat. The company is starting to reap the benefits of roughly two years of work to escape the pressures of its CTO - Crude Tall Oil - platform, the analyst tells investors in a research note. Ingevity is also seeing its high value add Performance Materials business enjoying growth despite muted end-market volumes, BMO adds.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Ingevity Corp (NGVT.N) is 12.01, compared to its 5-year average forward P/E of 13.21. For a more detailed relative valuation and DCF analysis to assess Ingevity Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
13.21
Current PE
12.01
Overvalued PE
16.50
Undervalued PE
9.93
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
8.64
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
9.80
Undervalued EV/EBITDA
7.47
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
1.86
Current PS
54.46
Overvalued PS
6.12
Undervalued PS
-2.40
Financials
Annual
Quarterly
FY2025Q3
YoY :
-11.62%
333.10M
Total Revenue
FY2025Q3
YoY :
-100.00%
N/A
Operating Profit
FY2025Q3
YoY :
-100.00%
N/A
Net Income after Tax
FY2025Q3
YoY :
-140.00%
1.18
EPS - Diluted
FY2025Q3
YoY :
+313.33%
117.80M
Free Cash Flow
FY2025Q3
YoY :
+16.62%
40.20
Gross Profit Margin - %
FY2025Q3
YoY :
+992.82%
19.78
FCF Margin - %
FY2025Q3
YoY :
-145.92%
13.06
Net Margin - %
FY2025Q3
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
107.0K
Volume
Months
0-12
1
429.8K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
NGVT News & Events
Events Timeline
2025-11-05 (ET)
2025-11-05
17:21:57
Ingevity projects FY25 revenue between $1.25B and $1.35B, with consensus at $1.28B
2025-11-05
17:20:44
Ingevity announces Q3 adjusted EPS of $1.52, surpassing consensus estimate of $1.39
2025-09-04 (ET)
2025-09-04
06:35:40
Ingevity maintains 2025 revenue forecast of $1.25B-$1.40B, with consensus at $1.31B
Sign Up For More Events
Sign Up For More Events
News
5.0
10-23NewsfilterIngevity appoints Ruth Castillo as senior vice president and head of Performance Materials
3.0
09-24NASDAQ.COMProjected Target Price for IJS Analyst: $122
8.5
09-08NASDAQ.COMNGVT Consents to Sell North Charleston CTO Refinery to Mainstream Pine
Sign Up For More News
People Also Watch
FCF
First Commonwealth Financial Corp
15.610
USD
-1.27%
GTY
Getty Realty Corp
26.910
USD
-1.54%
WTTR
Select Water Solutions Inc
11.330
USD
-1.31%
KOS
Kosmos Energy Ltd
1.410
USD
+2.92%
UNFI
United Natural Foods Inc
37.260
USD
+0.92%
NWBI
Northwest Bancshares Inc
11.620
USD
-3.09%
KRP
Kimbell Royalty Partners LP
13.160
USD
+0.30%
BBUC
Brookfield Business Corp
34.660
USD
-3.08%
NTB
Bank of NT Butterfield & Son Ltd
45.770
USD
-1.93%
SONO
Sonos Inc
16.290
USD
-2.10%
FAQ
What is Ingevity Corp (NGVT) stock price today?
The current price of NGVT is 46.2 USD — it has decreased -15.17 % in the last trading day.
What is Ingevity Corp (NGVT)'s business?
What is the price predicton of NGVT Stock?
What is Ingevity Corp (NGVT)'s revenue for the last quarter?
What is Ingevity Corp (NGVT)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Ingevity Corp (NGVT)'s fundamentals?
How many employees does Ingevity Corp (NGVT). have?